Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim

BACKGROUND Immune thrombocytopenia (ITP) in dogs is analogous to that in humans. Romiplostim, a novel thrombopoietin receptor (TPO-R) agonist, is currently used for the treatment of refractory ITP in humans, but not in dogs. Here, we describe the response to romiplostim in five dogs with refractory ITP. Five dogs with severe and refractory ITP (three primary and two secondary) received romiplos...

متن کامل

Erratum to: treatment of 5 dogs with immune-mediated thrombocytopenia using romiplostim

Erratum: n.b. The errors and associated corrections described in this document concerning the original manuscript were accountable to the production department handling this manuscript, and thus are no fault of the authors of this paper. Additionally, the online manuscript has now been updated with these corrections accordingly. The original version of the manuscript [1] contained incorrectly f...

متن کامل

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency

Immunosuppressive agents are the standard therapeutic approach for immune thrombocy-topenia (ITP). Their prolonged use may increase the risk of infectious complications, particularly when the patient is already at higher infectious risk. In this setting, the use of drugs with a mechanism of action alternative to immunosuppression, like thrombopoietin receptor agonists (TRAs), may find particula...

متن کامل

Romiplostim as a treatment for immune thrombocytopenia: a review

"Immune thrombocytopenia" (ITP) is an autoimmune disorder that leads to peripheral destruction, as well as a decreased production of platelets. ITP most commonly presents as mild mucocutaneous bleeding. Though it is rare, the leading cause of mortality in persons with ITP is intracranial hemorrhage and those that do not respond to therapy are at increased risk. Our understanding of the pathophy...

متن کامل

Self-administration of romiplostim in patients with chronic immune thrombocytopenia

Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City; New York Presbyterian Hospital, Departments of Pediatrics and Medicine, Division of Hematology, New York; Cancer Care Centers of South Texas/ US Oncology, San Antonio, Texas; 4 Jane Ann Nohl, Division of Hematology, University of Southern California Keck School of Medicine, Los Angeles; University of P...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMC Veterinary Research

سال: 2016

ISSN: 1746-6148

DOI: 10.1186/s12917-016-0718-4